Complicated urinary tract infection with ESBL risk — ABIM Board MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Empiric carbapenem therapy while cultures are pending
Septic complicated UTI with prior ESBL organism warrants empiric therapy active against resistant gram-negative pathogens, often a carbapenem, guided by prior cultures, local antibiogram, severity, allergies, and renal function. Nitrofurantoin and single-dose fosfomycin are inadequate for pyelonephritis or sepsis.
Reference: IDSA 2025 Complicated Urinary Tract Infection Guideline